__NUXT_JSONP__("/drugs/Cisplatin", (function(a,b,c,d,e,f,g){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[{brand:c,indication:b,manufacturer:d,splSetId:"2bf8d2fb-80c8-401d-8e9b-d58463f5e954"},{brand:a,indication:"1 INDICATIONS AND USAGE Cisplatin for injection is a platinum-based drug indicated for the treatment of: • Advanced testicular cancer ( 1.1 ) • Advanced ovarian cancer ( 1.2 ) • Advanced bladder cancer ( 1.3 ) 1.1 Advanced Testicular Cancer Cisplatin for injection is indicated for the treatment of advanced testicular cancer. 1.2 Advanced Ovarian Cancer Cisplatin for injection is indicated for the treatment of advanced ovarian cancer. 1.3 Advanced Bladder Cancer Cisplatin for injection is indicated for the treatment of advanced bladder cancer.",manufacturer:d,splSetId:"508496cb-3441-46b3-a4fe-e0d440e6adc6"},{brand:c,indication:b,manufacturer:"West-Ward Pharmaceuticals Corp",splSetId:"76aea034-6d58-4390-a164-36aa09c1f101"},{brand:e,indication:"INDICATIONS Cisplatin Injection is indicated as therapy to be employed as follows: Metastatic Testicular Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and\u002For radio therapeutic procedures. Metastatic Ovarian Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. An established combination consists of cisplatin and cyclophosphamide. Cisplatin Injection, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cisplatin Injection therapy. Advanced Bladder Cancer Cisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and\u002For radiotherapy.",manufacturer:"Gland Pharma Limited",splSetId:"a32820f7-9ff6-4c13-a96a-4483a943fe82"},{brand:a,indication:b,manufacturer:"Teva Parenteral Medicines, Inc.",splSetId:"a440f077-46f6-4688-a209-65bce38d1c92"},{brand:a,indication:f,manufacturer:"BluePoint Laboratories",splSetId:"a60c5173-6bc0-4c9d-9674-b3f4d68f79ba"},{brand:a,indication:f,manufacturer:"Accord Healthcare",splSetId:"b2b029f5-0d7e-4e7f-accc-b722aec34c68"},{brand:a,indication:"INDICATIONS Cisplatin Injection is indicated as therapy to be employed as follows: Metastatic Testicular Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. Metastatic Ovarian Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. An established combination consists of cisplatin and cyclophosphamide. Cisplatin Injection, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cisplatin Injection therapy. Advanced Bladder Cancer Cisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and\u002For radiotherapy.",manufacturer:"Athenex Pharmaceutical Division, LLC.",splSetId:"b822ef6e-fb50-4c86-843e-d656e38872d1"},{brand:a,indication:"INDICATIONS AND USAGE: Cisplatin Injection is indicated as therapy to be employed as follows: Metastatic Testicular Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. Metastatic Ovarian Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. An established combination consists of cisplatin and cyclophosphamide. Cisplatin Injection, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cisplatin Injection therapy. Advanced Bladder Cancer Cisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and\u002For radiotherapy.",manufacturer:"Fresenius Kabi USA, LLC",splSetId:"de6302d5-85f0-4116-a709-57826c2c84fe"}],id:a,nciThesaurus:{casRegistry:"15663-27-1",chebiId:"CHEBI:27899",chemicalFormula:"2Cl.Pt.2H3N",definition:"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.",fdaUniiCode:"Q20Q21Q62J",identifier:"C376",preferredName:a,semanticType:"Inorganic Chemical",subclassOf:["C1450"],synonyms:["(SP-4-2)-Diamminedichloroplatinum","Abiplatin","Blastolem","Briplatin","CDDP",e,"Cis-diammine-dichloroplatinum","Cis-diamminedichloridoplatinum","Cis-diamminedichloro Platinum (II)","Cis-diamminedichloroplatinum","Cis-dichloroammine Platinum (II)","Cis-platinous Diamine Dichloride","Cis-platinum","Cis-platinum II","Cis-platinum II Diamine Dichloride","Cismaplat",a,"Cisplatina","Cisplatinum","Cisplatyl","Citoplatino","Citosin","Cysplatyna","DDP","Lederplatin","Metaplatin","Neoplatin","Peyrone's Chloride","Peyrone's Salt","Placis","Plastistil","Platamine","Platiblastin","Platiblastin-S","Platinex","Platinol","Platinol- AQ","Platinol-AQ","Platinol-AQ VHA Plus","Platinoxan","Platinum","Platinum Diamminodichloride","Platinum, Diaminedichloro-, cis- (8CI)","Platiran","Platistin","Platosin","cisplatin"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FCisplatin",extension:".json",createdAt:g,updatedAt:g}}],fetch:{},mutations:void 0}}("Cisplatin","INDICATIONS Cisplatin Injection is indicated as therapy to be employed as follows: Metastatic Testicular Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. Metastatic Ovarian Tumors In established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and\u002For radiotherapeutic procedures. An established combination consists of Cisplatin Injection and cyclophosphamide. Cisplatin Injection, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cisplatin Injection therapy. Advanced Bladder Cancer Cisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and\u002For radiotherapy.","CISplatin","WG Critical Care, LLC","CISPLATIN","1 INDICATIONS AND USAGE Cisplatin injection is a platinum-based drug indicated for the treatment of: • Advanced testicular cancer ( 1.1 ) • Advanced ovarian cancer ( 1.2 ) • Advanced bladder cancer ( 1.3 ) 1.1 Advanced Testicular Cancer Cisplatin injection is indicated for the treatment of advanced testicular cancer. 1.2 Advanced Ovarian Cancer Cisplatin injection is indicated for the treatment of advanced ovarian cancer. 1.3 Advanced Bladder Cancer Cisplatin injection is indicated for the treatment of advanced bladder cancer.","2021-10-30T13:39:28.903Z")));